Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CHURCH & DWIGHT CO INC /DE/CHD · Entity 2509 | Director | July 01, 2026 | July 02, 2026 |
| Trade Desk, Inc.TTD · Entity 3752 | Director | July 09, 2026 | July 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CHURCH & DWIGHT CO INC /DE/
Report date July 01, 2026 · Filed July 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 33,321 |
Reported balance
After 2026-07-01 transaction · row 1
1 source rowRow 1 · 2026-07-01 · Grant · Acquired 1,471 · Balance 33,321 |
Trade Desk, Inc.
Report date July 09, 2026 · Filed July 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $19.75 · Expires 2036-07-09 | Direct | 25,505 |
Reported balance
After 2026-07-09 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-07-09 · Grant · Acquired 25,505 · Balance 25,505 F2: This option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy as an initial director equity grant. F1: Grant of option to purchase Class A Common Stock under the Issuer's 2025 Incentive Award Plan. The shares subject to the option vest in quarterly installments over the three-year period following the grant, subject to the Reporting Person's continuous service as a board member through such date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $19.75 · Expires 2036-07-09 | Direct | 20,893 |
Reported balance
After 2026-07-09 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-07-09 · Grant · Acquired 20,893 · Balance 20,893 F4: This option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy as an annual director equity grant, prorated from the date the Reporting Person became a non-employee director and the one-year anniversary of the Issuer's last annual meeting of stockholders. F3: Grant of option to purchase Class A Common Stock under the Issuer's 2025 Incentive Award Plan. The shares vest in four installments with 1,816 shares vesting August 4, 2026, 6,429 shares vesting November 4, 2026, 6,429 shares vesting February 4, 2027 and 6,219 shares vesting May 4, 2027 or, if earlier for each installment, the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting provided all then unvested shares shall vest in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $19.75 · Expires 2036-07-09 | Direct | 3,602 |
Reported balance
After 2026-07-09 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-07-09 · Grant · Acquired 3,602 · Balance 3,602 F6: This price represents the Black-Scholes value of an option using the average closing stock price for a share of the Issuer's Class A Common Stock for forty-five consecutive trading days ending on, and including, the grant date. This price was used to calculate the number of shares subject to the option granted. F7: These stock options were issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of director retainer and meeting fees of $50,000, prorated from the date the Reporting Person became a non-employee director to the date of the Issuer's next annual meeting of stockholders. F5: Grant of option to purchase Class A Common Stock under the Issuer's 2025 Incentive Award Plan. The shares vest in four installments with 313 shares vesting August 4, 2026, 1,108 shares vesting November 4, 2026, 1,108 shares vesting February 4, 2027 and 1,073 shares vesting May 4, 2027 or, if earlier for each installment, the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting provided all then unvested shares shall vest in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $19.75 · Expires 2036-07-09 | Direct | 3,602 |
Reported balance
After 2026-07-09 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-07-09 · Grant · Acquired 3,602 · Balance 3,602 F6: This price represents the Black-Scholes value of an option using the average closing stock price for a share of the Issuer's Class A Common Stock for forty-five consecutive trading days ending on, and including, the grant date. This price was used to calculate the number of shares subject to the option granted. F7: These stock options were issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of director retainer and meeting fees of $50,000, prorated from the date the Reporting Person became a non-employee director to the date of the Issuer's next annual meeting of stockholders. F8: Grant of option to purchase Class A Common Stock under the Issuer's 2025 Incentive Award Plan. The shares vest in four installments with 313 shares vesting August 4, 2026, 1,108 shares vesting November 4, 2026, 1,108 shares vesting February 4, 2027 and 1,073 shares vesting May 4, 2027 or, if earlier for each installment, the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting provided all then unvested shares shall vest in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the compensation committee of the board of directors immediately prior to such date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $19.75 · Expires 2036-07-09 | Direct | 900 |
Reported balance
After 2026-07-09 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-07-09 · Grant · Acquired 900 · Balance 900 F6: This price represents the Black-Scholes value of an option using the average closing stock price for a share of the Issuer's Class A Common Stock for forty-five consecutive trading days ending on, and including, the grant date. This price was used to calculate the number of shares subject to the option granted. F10: These stock options were issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of director retainer and meeting fees of $12,500, prorated from the date the Reporting Person became a non-employee director to the date of the Issuer's next annual meeting of stockholders. F9: Grant of option to purchase Class A Common Stock under the Issuer's 2025 Incentive Award Plan. The shares vest in four installments with 78 shares vesting August 4, 2026, 277 shares vesting November 4, 2026, 277 shares vesting February 4, 2027 and 268 shares vesting May 4, 2027 or, if earlier for each installment, the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting provided all then unvested shares shall vest in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the audit committee of the board of directors immediately prior to such date. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of option to purchase Class A Common Stock under the Issuer's 2025 Incentive Award Plan. The shares subject to the option vest in quarterly installments over the three-year period following the grant, subject to the Reporting Person's continuous service as a board member through such date.
F2: This option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy as an initial director equity grant.
F3: Grant of option to purchase Class A Common Stock under the Issuer's 2025 Incentive Award Plan. The shares vest in four installments with 1,816 shares vesting August 4, 2026, 6,429 shares vesting November 4, 2026, 6,429 shares vesting February 4, 2027 and 6,219 shares vesting May 4, 2027 or, if earlier for each installment, the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting provided all then unvested shares shall vest in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date.
F4: This option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy as an annual director equity grant, prorated from the date the Reporting Person became a non-employee director and the one-year anniversary of the Issuer's last annual meeting of stockholders.
F5: Grant of option to purchase Class A Common Stock under the Issuer's 2025 Incentive Award Plan. The shares vest in four installments with 313 shares vesting August 4, 2026, 1,108 shares vesting November 4, 2026, 1,108 shares vesting February 4, 2027 and 1,073 shares vesting May 4, 2027 or, if earlier for each installment, the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting provided all then unvested shares shall vest in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date.
F6: This price represents the Black-Scholes value of an option using the average closing stock price for a share of the Issuer's Class A Common Stock for forty-five consecutive trading days ending on, and including, the grant date. This price was used to calculate the number of shares subject to the option granted.
F7: These stock options were issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of director retainer and meeting fees of $50,000, prorated from the date the Reporting Person became a non-employee director to the date of the Issuer's next annual meeting of stockholders.
F8: Grant of option to purchase Class A Common Stock under the Issuer's 2025 Incentive Award Plan. The shares vest in four installments with 313 shares vesting August 4, 2026, 1,108 shares vesting November 4, 2026, 1,108 shares vesting February 4, 2027 and 1,073 shares vesting May 4, 2027 or, if earlier for each installment, the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting provided all then unvested shares shall vest in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the compensation committee of the board of directors immediately prior to such date.
F9: Grant of option to purchase Class A Common Stock under the Issuer's 2025 Incentive Award Plan. The shares vest in four installments with 78 shares vesting August 4, 2026, 277 shares vesting November 4, 2026, 277 shares vesting February 4, 2027 and 268 shares vesting May 4, 2027 or, if earlier for each installment, the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting provided all then unvested shares shall vest in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the audit committee of the board of directors immediately prior to such date.
F10: These stock options were issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of director retainer and meeting fees of $12,500, prorated from the date the Reporting Person became a non-employee director to the date of the Issuer's next annual meeting of stockholders.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 29, 2018 Filed Jul 3, 2018 13:20 UTC | CHURCH & DWIGHT CO INC /DE/ CHD · Entity 2509 | GrantCommon Stock | 2,070 | $53.16 | $110,041.20 |
DisclosureSEC source: 0001127602-18-022396 · form4.xml · nonDerivative · entry 1 Price Penry W · CIK 0001534034 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,843 Read SEC document |
| June 18, 2018 Filed Jun 19, 2018 12:44 UTC | CHURCH & DWIGHT CO INC /DE/ CHD · Entity 2509 | GrantStock Option · Derivative | 13,200 | $0.00 Strike: $50.28 | $0.00 |
DisclosureSEC source: 0001127602-18-021257 · form4.xml · derivative · entry 1 Price Penry W · CIK 0001534034 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,200 Underlying: Common Stock · 13,200 shares Expires 2028-06-18 Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 16:26 UTC | CHURCH & DWIGHT CO INC /DE/ CHD · Entity 2509 | GrantCommon Stock | 2,121 | $51.88 | $110,037.48 |
DisclosureSEC source: 0001127602-17-022721 · form4.xml · nonDerivative · entry 1 Price Penry W · CIK 0001534034 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,773 Read SEC document |
| June 19, 2017 Filed Jun 20, 2017 17:32 UTC | CHURCH & DWIGHT CO INC /DE/ CHD · Entity 2509 | GrantStock Option · Derivative | 11,590 | $0.00 Strike: $53.75 | $0.00 |
DisclosureSEC source: 0001127602-17-021890 · form4.xml · derivative · entry 1 Price Penry W · CIK 0001534034 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,590 Underlying: Common Stock · 11,590 shares Expires 2027-06-19 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.